On October 23, 2023, the EPA proposed a ban on TCE (trichloroethylene), used in cleaning products, tire repair sealants, degreasers, etc., stating there are readily available, safer alternatives. TCE has been shown to cause cancer, neurotoxicity, and reproductive toxicity. Read more here… URL: https://www.epa.gov/newsreleases/biden-harris-administration-proposes-ban-trichloroethylene-protect-public-toxic
Case Updates
10 posts
The Supreme Court has agreed to hear arguments this December concerning Purdue Pharma’s bankruptcy claims. Until then, the high court has blocked a $6 Billion settlement fund for cases related to opioid abuse. Purdue is “confident in the legality of [our] nearly universally supported Plan of Reorganization, and optimistic the […]
It was announced Saturday that the $2.4 billion Actos settlement agreement reached on April 28, 2015 is final. The finalization of this settlement with Takeda will benefit just over 10,000 persons claiming injury from its diabetes drug, Actos. Plaintiffs will now be required to submit medical proof of their injury […]
By Buck Daniel – Currently, we are placing our focus on two litigation fronts for our Risperdal cases. In the Philadelphia litigation there are hundreds of cases pending, whereas the California litigation is in its beginning stages. California Superior Judge William Highberger, who is overseeing the cases, along with the […]
By Kim Truongle – AMS – Our firm is part of a multi-firm settlement with AMS. If you are one of our AMS clients and have not yet been contacted by us, your contact information may be outdated, so please contact us at (800) 269-3050. Settlement administration is expected to […]
By Kim Truongle – ASR – We are pleased to report that all of our clients who elected to participate in the U.S. ASR Settlement earlier this year have been funded the majority of their claim. We currently await the Settlement Administrator’s review of bonus claims out of the Extraordinary […]
By Buck Daniel – March 31, 2014 – The Court overseeing our Pradaxa cases made slight changes to the bellwether discovery and trial schedule. The Plaintiffs’ Steering Committee was given additional time to disclose experts, and the first bellwether trial will begin September 8, 2014. The Court denied Defendants’ motion […]
By Howard Nations – November 20, 2013 – Recent activity in the DePuy ASR litigation increases the possibility of a settlement for ASR users who were required to have a revision or replacement of their implanted ASR hip device. Let me be clear up front that this is the beginning […]
By Kim Truongle – January 18, 2013 – Today, it was reported in the media that settlement discussions are occurring with regard to ASR cases. This information is speculative and unconfirmed. Instead, Plaintiffs’ counsel nationwide are focusing on trial preparation, with the first case set to begin in Los Angeles […]
By Kim Truongle – December 6, 2012 – There are transvaginal mesh cases against many manufacturers moving forward across the country. Johnson & Johnson pulled some of its mesh products off the market earlier this year. State-court cases against Johnson & Johnson are set to begin in New Jersey early next […]